GEM Co., Ltd. (002340.SZ) signed a strategic cooperation agreement with China Enfi to jointly promote the development of key mineral resources.
Grenerm (002340.SZ) announced that the company has signed a strategic cooperation agreement with China Enfei Engineering Technology Co., Ltd. Both parties will deepen their strategic cooperation in the development of key mineral resources, green, low-carbon and efficient utilization, and global layout. The agreement aims to enhance the global competitiveness of Chinese enterprises, provide solid support for safeguarding the strategic security of the country's key mineral resources, achieving self-reliance in key technologies, and promoting high-quality development.
GEM Co., Ltd. (002340.SZ) announced that it has signed a strategic cooperation agreement with China Enfi Engineering Technology Co., Ltd., aiming to deepen cooperation in key mineral resources development, green, low-carbon, and efficient utilization, as well as global layout. The agreement aims to enhance the global competitiveness of Chinese enterprises, provide solid support for safeguarding the country's strategic security of key mineral resources, achieving independent and self-reliant key technologies, and promoting high-quality development.
Related Articles
JP Morgan: Middle East oil production cuts to expand, expected to surpass 4 million barrels per day next week.
UBS: If oil prices rise to $80 per barrel, three major airlines in the mainland may all fall into losses.
HK Stock Market Move | LEADS BIOLABS-B(09887) rose more than 8% and officially entered the Hong Kong stock connect. The first patient has been enrolled in the phase II clinical trial of Vilyx II.
JP Morgan: Middle East oil production cuts to expand, expected to surpass 4 million barrels per day next week.
UBS: If oil prices rise to $80 per barrel, three major airlines in the mainland may all fall into losses.
HK Stock Market Move | LEADS BIOLABS-B(09887) rose more than 8% and officially entered the Hong Kong stock connect. The first patient has been enrolled in the phase II clinical trial of Vilyx II.
RECOMMEND
